Quach, Hang Fernyhough, Liam Henderson, Ross Corbett, Gillian Baker, Bart Browett, Peter Blacklock, Hilary Forsyth, Cecily Underhill, Craig Cannell, Paul others, Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study, British Journal of Haematology, (177), 441--448, 2017, 0007-1048, 1365-2141